Efficacy and Tolerability of Travoprost 0.004/Timolol 0.5 Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy

Figure 2

Least squares mean 8 a.m. IOP at week 4 by treatment groups (total population) and by region (ITT population). results for LS mean difference (one-sided 95% CI) between treatment groups (TTFC and beta-blocker); . Note. The values for regions (Latin America and Asia) are for descriptive purposes only. ANCOVA, analysis of covariance; CI, confidence interval; IOP, intraocular pressure; ITT, intent-to-treat; LS, least squares; TTFC, travoprost 0.004%/timolol 0.5% fixed-dose combination.